Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Gunnar Birgegård"'
Autor:
Marielle J. Wondergem, Antonio Almeida, Janaki Brolin, Carlos Fernandez de Larrea, Nathalie van Havre, Bas T. Hemker, Wietske Hollegien, José-Tomás Navarro, Mahesh Prahladan, Alicia Rovó, Gunnar Birgegård
Publikováno v:
HemaSphere, Vol 6, Iss 12, p e815 (2022)
Externí odkaz:
https://doaj.org/article/7b3617ecf9064a75851107262dcd1df0
Autor:
José-Tomás Navarro, Gunnar Birgegård, Janet Strivens, Wietske W.G. Hollegien, Naomi van Hattem, Manon T. Saris, Marielle J. Wondergem, Cheng-Hock Toh, Antonio M. Almeida
Publikováno v:
HemaSphere, Vol 3, Iss 5 (2019)
Externí odkaz:
https://doaj.org/article/e04e639c2af045fb90125cf9535b0f13
Autor:
Gunnar Birgegård, Carlos Besses, Martin Griesshammer, Luigi Gugliotta, Claire N. Harrison, Mohamed Hamdani, Jingyang Wu, Heinrich Achenbach, Jean-Jacques Kiladjian
Publikováno v:
Haematologica, Vol 103, Iss 1 (2018)
Evaluation of Anagrelide (Xagrid®) Efficacy and Long-term Safety, a phase IV, prospective, non-interventional study performed in 13 European countries enrolled high-risk essential thrombocythemia patients treated with cytoreductive therapy. The prim
Externí odkaz:
https://doaj.org/article/4832ed24b0f14364ad4a8d5a44c831a5
Publikováno v:
Högre Utbildning, Vol 1, Iss 1, Pp 27-37 (2011)
Pedagogisk meritering och pedagogiska meritportföljer har under det senaste decenniet fått ökad uppmärksamhet. Idag (mars 2011) ger en sökning på Google® 6 140 respektive 1 990 träffar på dessa två sökord. Många av träffarna på Google®
Externí odkaz:
https://doaj.org/article/1b495886e0c24af5ad9f96ccb0608819
Autor:
Gunnar Birgegård
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2008, Iss Issue 2, Pp 527-539 (2008)
Gunnar BirgegårdDepartment of Haematology, University Hospital, Uppsala, SwedenAbstract: Anemia is common in cancer, and lymphoproliferative disease is no exception. Erythropoiesis-stimulating agents (ESA) have been used for renal anemia since 1986,
Externí odkaz:
https://doaj.org/article/5e71e7a3c4e04fedbc989e720c3fdc2f
Autor:
Luigi Gugliotta, Carlos Besses, Martin Griesshammer, Claire Harrison, Jean-Jacques Kiladjian, Ruth Coll, Jonathan Smith, Brihad Abhyankar, Gunnar Birgegård
Publikováno v:
Haematologica, Vol 99, Iss 4 (2014)
Available information is limited regarding the use of cytoreductive combination therapy in high-risk patients with essential thrombocythemia. This analysis aims to evaluate the clinical relevance and patterns of cytoreductive combination treatment in
Externí odkaz:
https://doaj.org/article/59b0e7c10fc24016b69519f4b353e6aa
Publikováno v:
Journal of Health Economics and Outcomes Research
**Background:** In order to facilitate sound economic evaluations of novel treatments, health-economic models of polycythemia vera (PV) must combine effects on surrogate endpoints in trials with disease progression (DP) and mortality in long-term coh
Externí odkaz:
https://doaj.org/article/61b7366a7d344ab1a541e664f07c4df8
Publikováno v:
Journal of Health Economics and Outcomes Research
**Background:** In order to facilitate sound economic evaluations of novel treatments, health-economic models of polycythemia vera (PV) must combine effects on surrogate endpoints in trials with disease progression (DP) and mortality in long-term coh
Autor:
Emanuela Sant'Antonio, Elisa Rumi, Jyoti Nangalia, Claire N. Harrison, Gunnar Birgegård, Tiziano Barbui, Alberto Alvarez-Larrán, Francesca Palandri, Ruben A. Mesa, Jean-Jacques Kiladjian, Jean Christophe Ianotto, Steffen Koschmieder, Juan Carlos Hernández-Boluda, Martin Griesshammer
Publikováno v:
The Lancet. Haematology. 8(9)
Recommendations regarding management of essential thrombocythaemia rely on studies done before the discovery of the CALR mutation. On May 20, 2020, the European LeukemiaNet annual meeting was held with the goal to identify unmet clinical needs in mye
Autor:
Claus Henrik Nielsen, Christian Enevold, Ole Birger Pedersen, Waleed Ghanima, Anders Lindholm Sørensen, Håvar Knutsen, Gunnar Birgegård, Hans Carl Hasselbalch, Bjorn Andreasson, Elisabeth Ejerblad, Erik Ahlstrand, Jan Samuelsson
Publikováno v:
European Journal of Haematology. 102:235-240
OBJECTIVES The study investigates the hypothesis that inflammation in myelofibrosis (MF) like in myeloma and lymphoma, may disturb iron distribution and contribute to anaemia. METHODS A cross-sectional study of 80 MF and 23 ET patients was performed.